PRCT Financials
Procept Biorobotics Corp - Financial statements & key metrics
Stock Price
$20.91
Market Cap
$1.52B
P/E Ratio
-11.9
EPS
$-1.53
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$224.50M
Gross Profit
-
Operating Income
-
Net Income
$-91.41M
EPS (Diluted)
$-1.75
Balance Sheet Highlights
Total Assets
$534.02M
Total Liabilities
$131.80M
Shareholders Equity
-
Cash & Equivalents
$333.73M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-99.21M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-27.8%
Net Margin
-28.2%
ROE
-27.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PRCT revenue?
PRCT's most recent quarterly revenue was $224.50M. Annual revenue can be calculated by summing the four most recent quarters.
Is PRCT profitable?
PRCT reported a loss of $91.41M in the most recent quarter. The net profit margin is -28.2%.
What is PRCT market cap?
PRCT has a market capitalization of $1.52B, making it a small-cap stock.
Does PRCT have debt?
View PRCT's balance sheet for debt information.
What is PRCT cash flow?
Cash flow data is available in the full financial statements.